Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
1.120
-0.010 (-0.88%)
At close: Jun 26, 2026, 4:00 PM EDT
1.090
-0.030 (-2.68%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Cognition Therapeutics Employees
Cognition Therapeutics had 14 employees as of December 31, 2025. The number of employees decreased by 14 or -50.00% compared to the previous year.
Employees
14
Change (1Y)
-14
Growth (1Y)
-50.00%
Revenue / Employee
n/a
Profits / Employee
-$1,398,357
Market Cap
100.24M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Cibus | 118 |
| Alps Group | 93 |
| Pelthos Therapeutics | 92 |
| Vivani Medical | 42 |
| Aardvark Therapeutics | 40 |
| Biomea Fusion | 40 |
| Cue Biopharma | 29 |
| Black Diamond Therapeutics | 21 |
CGTX News
- 4 days ago - Cognition Therapeutics gets FDA feedback on zervimesine study - TheFly
- 4 days ago - Cognition Therapeutics Aligns on Key Aspects of Pivotal Study for Zervimesine (CT1812) in DLB Psychosis Following Receipt of FDA Meeting Minutes - GlobeNewsWire
- 11 days ago - Cognition Therapeutics Transcript: AGM 2026 - Transcripts
- 12 days ago - Cognition Therapeutics gets notice of allowance from USPTO for zervimesine - TheFly
- 12 days ago - Cognition Therapeutics Announces New Composition of Matter Patent, Extending Patent Protection for Lead Candidate, Zervimesine (CT1812) Through 2045 - GlobeNewsWire
- 23 days ago - Cognition Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 24 days ago - Cognition Therapeutics Slides: Investor presentation - Filings
- 27 days ago - Cognition Therapeutics Participating in Upcoming Investor Conferences - GlobeNewsWire